Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021)
Insight Molecular Diagnostics (IMDX) posted Acquisitions of $607000.0 for Q1 2021, down 90.19% sequentially from $6.2 million in Q1 2020, and down 90.19% YoY from $6.2 million in Q1 2020.
Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021) Analysis & Trends
Insight Molecular Diagnostics has reported Acquisitions for 2 years, with the latest figure at $607000.0 in Q1 2021.
- Quarterly Acquisitions fell 90.19% year-over-year to $607000.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $607000.0 (down 90.19% YoY) and the FY2021 annual result came in at $607000.0, down 90.19% from the prior year.
- Acquisitions fell to $607000.0 in Q1 2021 per IMDX's latest filing, from $6.2 million in the prior quarter.
- Over five years, Acquisitions peaked at $6.2 million in Q1 2020 and troughed at $607000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 163.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 2.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 607,000.00 |
| Mar 31, 2020 | 6.19 Mn |